SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000186
Filing Date
2023-11-21
Accepted
2023-11-21 06:44:05
Documents
14
Period of Report
2023-11-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20231120.htm   iXBRL 8-K 41884
2 EX-2.1 exhibit21-evelobiosciences.htm EX-2.1 22858
6 evlo-20231120_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000186.txt   227088

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20231120.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20231120_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20231120_pre.xml EX-101.PRE 13049
8 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20231120_htm.xml XML 2837
Mailing Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231424463
SIC: 2834 Pharmaceutical Preparations